Vanda Pharmaceuticals Inc.
VNDA
$4.98
$0.061.22%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 374.64M | 376.26M | 387.68M | 394.14M | 388.26M |
| Total Receivables | 47.10M | 42.75M | 41.86M | 36.71M | 34.16M |
| Inventory | 1.73M | 1.61M | 1.47M | 1.51M | 1.36M |
| Prepaid Expenses | 15.42M | 11.76M | 8.17M | 7.07M | 9.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 438.89M | 432.39M | 439.18M | 439.43M | 432.95M |
|
|
|||||
| Total Current Assets | 438.89M | 432.39M | 439.18M | 439.43M | 432.95M |
| Net Property, Plant & Equipment | 12.68M | 8.19M | 8.68M | 9.05M | 9.14M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 114.10M | 115.85M | 117.60M | 119.35M | 121.37M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 90.54M | 88.69M | 85.91M | 84.86M | 84.99M |
| Total Assets | 656.20M | 645.12M | 651.37M | 652.68M | 648.44M |
|
|
|||||
| Total Accounts Payable | 3.50M | 5.81M | 2.27M | 4.34M | 7.15M |
| Total Accrued Expenses | 31.32M | 31.04M | 34.91M | 31.02M | 28.92M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.27M | 2.45M | 2.43M | 2.41M | 2.40M |
| Total Finance Division Other Current Liabilities | 60.90M | 49.79M | 54.19M | 55.57M | 49.24M |
| Total Other Current Liabilities | 60.90M | 49.79M | 54.19M | 55.57M | 49.24M |
| Total Current Liabilities | 99.98M | 89.09M | 93.79M | 93.34M | 87.70M |
|
|
|||||
| Total Current Liabilities | 99.98M | 89.09M | 93.79M | 93.34M | 87.70M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.09M | 5.49M | 6.01M | 6.51M | 7.01M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.59M | 9.32M | 9.06M | 8.83M | 8.83M |
| Total Liabilities | 117.66M | 103.89M | 108.86M | 108.69M | 103.53M |
|
|
|||||
| Common Stock & APIC | 712.76M | 709.90M | 706.90M | 703.92M | 700.33M |
| Retained Earnings | -174.29M | -169.38M | -164.06M | -159.54M | -155.39M |
| Treasury Stock & Other | 74.00K | 702.00K | -330.00K | -383.00K | -30.00K |
| Total Common Equity | 538.55M | 541.22M | 542.52M | 544.00M | 544.91M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 538.55M | 541.22M | 542.52M | 544.00M | 544.91M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 538.55M | 541.22M | 542.52M | 544.00M | 544.91M |
|
|
|||||
